We are live on ! Find out more
AC

Antara Capital Portfolio holdings

AUM $30.2K
1-Year Est. Return 5.24%
This Fund
S&P 500
This Quarter Est. Return
+93.35%
1 Year Est. Return
-5.24%
3 Year Est. Return
-39.78%
5 Year Est. Return
-45.29%
10 Year Est. Return
–
AUM
$490K
AUM Growth
-$629K
Cap. Flow
-$1.35M
Cap. Flow %
-275.27%
Top 10 Hldgs %
100%
Holding
4
New
2
Increased
–
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
ASBP
Aspire Biopharma
ASBP
+$84.6K
2
ASBPW
Aspire Biopharma Warrant
ASBPW
+$10.5K

Top Sells

Rank Stock Value
1
CURR
Currenc Group
CURR
+$1.04M
2
RZLV
Rezolve AI
RZLV
+$404K

Sector Composition

Rank Sector Weight
1 Technology 90.21%
2 Healthcare 8.53%
3 Miscellaneous 1.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CURR
1
Currenc Group
CURR
$378M
$442K 90.21%
263,200
-615,300
-70% -$1.04M
ASBP
2
Aspire Biopharma
ASBP
$11.9M
$41.8K 8.53%
+169
New +$84.6K
ASBPW
3
Aspire Biopharma Warrant
ASBPW
$362K
$6.21K 1.27%
+207,693
New +$10.5K
RZLV
4
Rezolve AI
RZLV
$1.18B
– –
-131,250
Closed -$404K

Similar funds

SNN
Shen Neil Nanpeng $36.3K AUM 179.45% 1-Year Est. Return
FFVM
Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
NA
Newport Asia San Francisco, California $2.21M AUM
IVSFI
IA Venture Strategies Fund II New York $4.08M AUM 174.71% 1-Year Est. Return
FFGM
Founders Fund Growth Management San Francisco, California $7.04M AUM 82.06% 1-Year Est. Return

Antara Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Antara Capital held 4 positions worth $490K, down 56% from $1.12M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Antara Capital withdrew a net $1.35M in Q3 2025, closing 1 position and reducing 1 holding. Its most notable exit was Rezolve AI, an estimated $404K position sold in full.

By sector, the portfolio is most concentrated in Technology at 90% of assets, down from 100% a quarter earlier, followed by Healthcare and Miscellaneous.

Against the trend, Antara Capital opened a new position in Aspire Biopharma worth $41.8K.

  • Antara Capital's largest Q3 2025 buy was Aspire Biopharma: 169 shares worth $41.8K.
  • Antara Capital's biggest Q3 2025 reduction was Currenc Group, cutting an estimated $1.04M.
  • Antara Capital fully exited Rezolve AI in Q3 2025, selling an estimated $404K.
  • Antara Capital's ten largest holdings make up 100% of its $490K portfolio in Q3 2025.
  • Antara Capital opened 2 new positions and closed 1 in Q3 2025.
  • Antara Capital's portfolio value fell 56% quarter-over-quarter to $490K.

Based on Antara Capital's 13F filing for Q3 2025, filed 14 Nov 2025.